Stoke Therapeutics, Inc.
STOK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $128 | $191 | $114 | $145 |
| Short-Term Investments | $89 | $10 | $116 | $75 |
| Receivables | $1 | $0 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $15 | $14 | $14 | $9 |
| Total Curr. Assets | $233 | $215 | $244 | $229 |
| Property Plant & Equip (Net) | $8 | $12 | $11 | $9 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $30 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $39 | $13 | $12 | $10 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $272 | $228 | $256 | $239 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $1 | $2 |
| Short-Term Debt | $2 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $19 | $15 | $15 | $0 |
| Other Curr. Liab. | $16 | $12 | $13 | $13 |
| Total Curr. Liab. | $40 | $31 | $31 | $17 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $33 | $37 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $5 | $3 | $4 |
| Total NC Liab. | $2 | $38 | $40 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $2 | $2 |
| Total Liabilities | $43 | $69 | $71 | $21 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$491 | -$402 | -$297 | -$196 |
| AOCI | -$0 | -$0 | -$1 | -$0 |
| Other Equity | $720 | $561 | $483 | $414 |
| Total Equity | $229 | $160 | $185 | $218 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $272 | $228 | $256 | $239 |
| Net Debt | -$126 | -$189 | -$111 | -$143 |